Other
2030
Guardant Health 2030 decreased by 21.6% to $600K in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 21.6%, from $765K to $600K.
Analysis
StatementBalance Sheet Statement
SectionOther
First reportedQ1 2020
Last reportedQ1 2026May 7, 2026
Metric ID:
other_finite_lived_intangible_assets_amortization_expens_4a0a03Historical Data
15 periods
| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.71M | $1.71M | $1.21M | $1.21M | $1.21M | $1.11M | $1.11M | $1.11M | $1.11M | $1.11M | $1.11M | $765K | $765K | $765K | $600K |
| QoQ Change | — | +0.0% | -28.9% | +0.0% | +0.0% | -8.7% | +0.0% | +0.0% | +0.2% | +0.0% | +0.0% | -31.0% | +0.0% | +0.0% | -21.6% |
| YoY Change | — | — | — | -28.9% | -28.9% | -8.7% | -8.7% | -8.7% | +0.2% | +0.2% | +0.2% | -31.0% | -31.0% | -31.0% | -21.6% |
Range$600K – $1.71M
CAGR-25.8%
Avg YoY Growth-16.5%
Median YoY Growth-15.1%
2030 at Other Companies
Frequently Asked Questions
- What is Guardant Health's 2030?
- Guardant Health (GH) reported 2030 of $600K in Q1 2026.
- How has Guardant Health's 2030 changed year-over-year?
- Guardant Health's 2030 decreased by 21.6% year-over-year, from $765K to $600K.